ZA722243B - Insulin product - Google Patents

Insulin product

Info

Publication number
ZA722243B
ZA722243B ZA722243A ZA722243A ZA722243B ZA 722243 B ZA722243 B ZA 722243B ZA 722243 A ZA722243 A ZA 722243A ZA 722243 A ZA722243 A ZA 722243A ZA 722243 B ZA722243 B ZA 722243B
Authority
ZA
South Africa
Prior art keywords
insulin product
insulin
product
Prior art date
Application number
ZA722243A
Other languages
English (en)
Inventor
R Jackson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA722243B publication Critical patent/ZA722243B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA722243A 1971-04-30 1972-04-04 Insulin product ZA722243B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (1)

Publication Number Publication Date
ZA722243B true ZA722243B (en) 1973-11-28

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA722243A ZA722243B (en) 1971-04-30 1972-04-04 Insulin product

Country Status (23)

Country Link
US (1) US3758683A (cs)
JP (1) JPS5735185B1 (cs)
BE (1) BE782651A (cs)
CA (1) CA976085A (cs)
CH (1) CH566784A5 (cs)
CS (1) CS209458B2 (cs)
DD (1) DD100708A5 (cs)
DE (1) DE2219635C3 (cs)
DK (1) DK131760C (cs)
ES (1) ES402176A1 (cs)
FI (1) FI49773C (cs)
FR (1) FR2134658B1 (cs)
GB (1) GB1385086A (cs)
HU (1) HU166989B (cs)
IL (1) IL39181A (cs)
NL (1) NL178258C (cs)
NO (1) NO137178C (cs)
PL (1) PL86966B1 (cs)
RO (1) RO64387A (cs)
SE (1) SE378066B (cs)
SU (1) SU508162A3 (cs)
YU (1) YU36155B (cs)
ZA (1) ZA722243B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
WO1988002633A1 (en) * 1986-10-20 1988-04-21 Novo Industri A/S Protamine zinc insulin preparations
JP2606915B2 (ja) * 1987-02-25 1997-05-07 ノボ ノルディスク アクティーゼルスカブ 新規インシュリン誘導体
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
CR20170369A (es) 2008-10-17 2017-11-01 Sanofi Aventis Deutschland COMBINACIÓN DE UNA INSULINA Y UN AGONISTA DE GLP-1 (Divisional 2011-0188)
WO2011058082A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin
PL2498802T3 (pl) 2009-11-13 2015-06-30 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
SG187904A1 (en) 2010-08-30 2013-04-30 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
EP2750699B1 (en) 2011-08-29 2015-07-22 Sanofi-Aventis Deutschland GmbH Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP3229828B1 (en) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
RS65380B1 (sr) 2017-08-24 2024-04-30 Novo Nordisk As Glp-1 kompozicije i njihova upotreba
IL294520A (en) 2020-02-18 2022-09-01 Novo Nordisk As Pharmaceutical formulations
CN118949061A (zh) * 2023-08-07 2024-11-15 浙江大学 一种糖响应鱼精蛋白胰岛素及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
CA976085A (en) 1975-10-14
YU36155B (en) 1982-02-25
DK131760C (da) 1976-02-02
RO64387A (fr) 1979-07-15
NL178258B (nl) 1985-09-16
DK131760B (da) 1975-09-01
NL7205865A (cs) 1972-11-01
DD100708A5 (cs) 1973-10-05
HU166989B (cs) 1975-07-28
DE2219635B2 (de) 1980-11-27
GB1385086A (en) 1975-02-26
PL86966B1 (cs) 1976-06-30
FI49773C (fi) 1975-10-10
ES402176A1 (es) 1975-03-01
FR2134658A1 (cs) 1972-12-08
CH566784A5 (cs) 1975-09-30
NO137178C (no) 1978-01-18
BE782651A (fr) 1972-10-26
DE2219635C3 (de) 1981-10-15
CS209458B2 (en) 1981-12-31
YU114272A (en) 1981-06-30
US3758683A (en) 1973-09-11
NL178258C (nl) 1986-02-17
JPS5735185B1 (cs) 1982-07-27
SU508162A3 (ru) 1976-03-25
NO137178B (no) 1977-10-10
IL39181A (en) 1974-09-10
FI49773B (cs) 1975-06-30
SE378066B (cs) 1975-08-18
DE2219635A1 (de) 1972-11-09
FR2134658B1 (cs) 1975-10-17
IL39181A0 (en) 1972-06-28

Similar Documents

Publication Publication Date Title
ZM9272A1 (en) Dental product
ZA722243B (en) Insulin product
ZA72277B (en) Insulin derivatives
HK25976A (en) Products containing fibres
EG11093A (en) Smokable products
AU452952B2 (en) Novel products
ZA727879B (en) Fish product
ZA723187B (en) Fish product
GB1396532A (en) Foamed products
AU4878672A (en) Products
IL37967A0 (en) Medicament container
ZA717375B (en) Novel products
ZA722789B (en) Novel products
AU4604872A (en) Medicines with ulcer-healing effect
ZA722225B (en) Conveyor
ZA727880B (en) Protein product
AU4752972A (en) Novel products
ZA728170B (en) Smokable products
JPS5123342A (en) Kazariito no seizoho
AU460580B2 (en) Insulin product
AU4090872A (en) Insulin product
JPS51110123A (en) gasorinkikan no judokugasuboshihoho
YU183771A (en) Preklopni mehanizem s trenutnim preklopom kot sestavna
ZA727968B (en) Insulin derivatives
AU457258B2 (en) Product